| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $348.7M | +3.9% |
| Cost of Revenue | $194.4M | +7.4% |
| Gross Profit | $154.3M | -0.3% |
| R&D Expense | $19.4M | -10.2% |
| SG&A Expense | $67.4M | -7.2% |
| Operating Income | -$30.2M | +29.0% |
| Pre-tax Income | -$23.4M | +35.9% |
| Income Tax | -$632K | -7.5% |
| Net Income | -$22.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.7M | -8.8% |
| Accounts Receivable | $38.9M | +31.5% |
| Inventory | $26.0M | +4.7% |
| Current Assets | $198.3M | +6.9% |
| Total Assets | $298.6M | +0.8% |
| Current Liabilities | $63.5M | -17.1% |
| Total Liabilities | $106.4M | -13.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -289.7% |
| Capital Expenditures | $2.5M | -24.9% |
| Investing Cash Flow | -$26.2M | -87.5% |
| Financing Cash Flow | $24.2M | +9025.3% |
| Free Cash Flow | -$13.7M | -637.9% |
| +36.6% |
| EPS (Basic) | -$0.86 | +43.4% |
| EPS (Diluted) | -$0.86 | +43.4% |
| Stockholders' Equity |
| $192.2M |
| +10.6% |